The multiple roles of p53 in the pathogenesis of HIV associated dementia

Biochemical and Biophysical Research Communications

Volumn 331, Issue 3, 2005, Pages 799-809

  Garden, Gwenn A ^a   Morrison, Richard S ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; CANCER INHIBITION; DEMENTIA; DISEASE ASSOCIATION; EXCITOTOXICITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; NERVE DEGENERATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; REVIEW; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 18144380368     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.03.185     Document Type: Review

References (117)

1. S.F. An, M. Groves, F. Gray, and F. Scaravilli Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals J. Neuropathol. Exp. Neurol. 58 1999 1156 1162
2. J.C. McArthur, N. Sacktor, and O. Selnes Human immunodeficiency virus-associated dementia Semin. Neurol. 19 1999 129 150
3. N. Sacktor, M.P. McDermott, K. Marder, G. Schifitto, O.A. Selnes, J.C. McArthur, Y. Stern, S. Albert, D. Palumbo, K. Kieburtz, J.A. De Marcaida, B. Cohen, and L. Epstein HIV-associated cognitive impairment before and after the advent of combination therapy J. Neurovirol. 8 2002 136 142
4. R.H. Enting, R.M. Hoetelmans, J.M. Lange, D.M. Burger, J.H. Beijnen, and P. Portegies Antiretroviral drugs and the central nervous system [editorial] AIDS 12 1998 1941 1955
5. T.K. Smit, B.J. Brew, W. Tourtellotte, S. Morgello, B.B. Gelman, and N.K. Saksena Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment J. Virol. 78 2004 10133 10148
6. J.K. Neuenburg, H.R. Brodt, B.G. Herndier, M. Bickel, P. Bacchetti, R.W. Price, R.M. Grant, and W. Schlote HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy J. AIDS 31 2002 171 177
7. G.J. Dore, A. McDonald, Y. Li, J.M. Kaldor, and B.J. Brew Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy AIDS 17 2003 1539 1545
8. S.L. Letendre, M. Cherner, R. Ellis, J. Marquie-Beck, B. Gragg, T. Marcotte, R.K. Heaton, J.A. McCutchan, I. Grant, The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease, AIDS (2004) in press
9. V.G. Valcour, C.M. Shikuma, M.R. Watters, and N.C. Sacktor Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms AIDS 18 Suppl. 1 2004 S79 S86
10. E.L. Ryan, S. Morgello, K. Isaacs, M. Naseer, and P. Gerits Neuropsychiatric impact of hepatitis C on advanced HIV Neurology 62 2004 957 962
11. J.N. Inungu, E.D. Mokotoff, and J.B. Kent Characteristics of HIV infection in patients fifty years or older in Michigan AIDS Patient Care STDS 15 2001 567 573
12. J.P. Moore, A. Trkola, and T. Dragic Co-receptors for HIV-1 entry Curr. Opin. Immunol. 9 1997 551 562
13. B.J. Doranz, J.F. Berson, J. Rucker, and R.W. Doms Chemokine receptors as fusion cofactors for human immunodeficiency virus type 1 (HIV-1) Immunol. Res. 16 1997 15 28
14. B.J. Doranz, J. Rucker, Y. Yi, R.J. Smyth, M. Samson, S.C. Peiper, M. Parmentier, R.G. Collman, and R.W. Doms A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors Cell 85 1996 1149 1158
15. R.T. Reddy, C.L. Achim, D.A. Sirko, S. Tehranchi, F.G. Kraus, F. Wong-Staal, and C.A. Wiley Sequence analysis of the V3 loop in brain and spleen of patients with HIV encephalitis AIDS Res. Hum. Retroviruses 12 1996 477 482
16. A.L. Cunningham, S. Li, J. Juarez, G. Lynch, M. Alali, and H. Naif The level of HIV infection of macrophages is determined by interaction of viral and host cell genotypes J. Leukoc. Biol. 68 2000 311 317
17. A.I. Qureshi, D.L. Hanson, J.L. Jones, and R.S. Janssen Estimation of the temporal probability of human immunodeficiency virus (HIV) dementia after risk stratification for HIV-infected persons Neurology 50 1998 392 397
18. R.J. Ellis, D.J. Moore, M.E. Childers, S. Letendre, J.A. McCutchan, T. Wolfson, S.A. Spector, K. Hsia, R.K. Heaton, and I. Grant Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA Arch. Neurol. 59 2002 923 928
19. J. Zheng, A. Ghorpade, D. Niemann, R.L. Cotter, M.R. Thylin, L. Epstein, J.M. Swartz, R.B. Shepard, X. Liu, A. Nukuna, and H.E. Gendelman Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis: implications for human immunodeficiency virus type 1-associated dementia J. Virol. 73 1999 8256 8267
20. D.E. Brenneman, G.L. Westbrook, S.P. Fitzgerald, D.L. Ennist, K.L. Elkins, M.R. Ruff, and C.B. Pert Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide Nature 335 1988 639 642
21. S.M. Toggas, E. Masliah, E.M. Rockenstein, G.F. Rall, C.R. Abraham, and L. Mucke Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice [see comments] Nature 367 1994 188 193
22. D.R. New, M. Ma, L.G. Epstein, A. Nath, and H.A. Gelbard Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures J. Neurovirol. 3 1997 168 173
23. S.C. Piller, P. Jans, P.W. Gage, and D.A. Jans Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: implications for AIDS pathology Proc. Natl. Acad. Sci. USA 95 1998 4595 4600
24. L. Poluektova, S. Gorantla, J. Faraci, K. Birusingh, H. Dou, and H.E. Gendelman Neuroregulatory events follow adaptive immune-mediated elimination of HIV-1-infected macrophages: studies in a murine model of viral encephalitis J. Immunol. 172 2004 7610 7617
25. Y. Persidsky, and H.E. Gendelman Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection J. Leukoc. Biol. 74 2003 691 701
26. M.A. Cosenza, M.L. Zhao, Q. Si, and S.C. Lee Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis Brain Pathol. 12 2002 442 455
27. G. Trillo-Pazos, A. Diamanturos, L. Rislove, T. Menza, W. Chao, P. Belem, S. Sadiq, S. Morgello, L. Sharer, and D.J. Volsky Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection Brain Pathol. 13 2003 144 154
28. J. Torres-Munoz, P. Stockton, N. Tacoronte, B. Roberts, R.R. Maronpot, and C.K. Petito Detection of HIV-1 gene sequences in hippocampal neurons isolated from postmortem AIDS brains by laser capture microdissection J. Neuropathol. Exp. Neurol. 60 2001 885 892
29. T. Fischer-Smith, S. Croul, A.E. Sverstiuk, C. Capini, D. L'Heureux, E.G. Regulier, M.W. Richardson, S. Amini, S. Morgello, K. Khalili, and J. Rappaport CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection J. Neurovirol. 7 2001 528 541
30. G. Venturi, M. Catucci, L. Romano, P. Corsi, F. Leoncini, P.E. Valensin, and M. Zazzi Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples J. Infect Dis. 181 2000 740 745
31. K. Stingele, J. Haas, T. Zimmermann, R. Stingele, C. Hubsch-Muller, M. Freitag, B. Storch-Hagenlocher, M. Hartmann, and B. Wildemann Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy Neurology 56 2001 355 361
32. G.J. Dal Pan, H. Farzadegan, O. Selnes, D.R. Hoover, E.N. Miller, R.L. Skolasky, T.E. Nance-Sproson, and J.C. McArthur Sustained cognitive decline in HIV infection: relationship to CD4+ cell count, plasma viremia and p24 antigenemia J. Neurovirol. 4 1998 95 99
33. E. Masliah, R.K. Heaton, T.D. Marcotte, R.J. Ellis, C.A. Wiley, M. Mallory, C.L. Achim, J.A. McCutchan, J.A. Nelson, J.H. Atkinson, and I. Grant Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center Ann. Neurol. 42 1997 963 972
34. S.L. Wesselingh, C. Power, J.D. Glass, W.R. Tyor, J.C. McArthur, J.M. Farber, J.W. Griffin, and D.E. Griffin Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia Ann. Neurol. 33 1993 576 582
35. W.R. Tyor, J.D. Glass, J.W. Griffin, P.S. Becker, J.C. McArthur, L. Bezman, and D.E. Griffin Cytokine expression in the brain during the acquired immunodeficiency syndrome Ann. Neurol. 31 1992 349 360
36. C.L. Achim, M.P. Heyes, and C.A. Wiley Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains J. Clin. Invest. 91 1993 2769 2775
37. P. Genis, M. Jett, E.W. Bernton, T. Boyle, H.A. Gelbard, K. Dzenko, R.W. Keane, L. Resnick, Y. Mizrachi, and D.J. Volsky Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease J. Exp. Med. 176 1992 1703 1718
38. S.L. Wesselingh, J. Glass, J.C. McArthur, J.W. Griffin, and D.E. Griffin Cytokine dysregulation in HIV-associated neurological disease Adv. Neuroimmunol. 4 1994 199 206
39. S.L. Wesselingh, K. Takahashi, J.D. Glass, J.C. McArthur, J.W. Griffin, and D.E. Griffin Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry J. Neuroimmunol. 74 1997 1 8
40. V. Fontaine, S. Mohand-Said, N. Hanoteau, C. Fuchs, K. Pfizenmaier, and U. Eisel Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2 J. Neurosci. 22 2002 RC216
41. L. Yang, K. Lindholm, Y. Konishi, R. Li, and Y. Shen Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways J. Neurosci. 22 2002 3025 3032
42. P. Bezzi, M. Domercq, L. Brambilla, R. Galli, D. Schols, E. De Clercq, A. Vescovi, G. Bagetta, G. Kollias, J. Meldolesi, and A. Volterra CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity Nat. Neurosci. 4 2001 702 710
43. M.W. Yeh, M. Kaul, J. Zheng, H.S. Nottet, M. Thylin, H.E. Gendelman, and S.A. Lipton Cytokine-stimulated, but not HIV-infected, human monocyte-derived macrophages produce neurotoxic levels of l-cysteine J. Immunol. 164 2000 4265 4270
44. C.M. Luetjens, N.T. Bui, B. Sengpiel, G. Munstermann, M. Poppe, A.J. Krohn, E. Bauerbach, J. Krieglstein, and J.H. Prehn Delayed mitochondrial dysfunction in excitotoxic neuron death: cytochrome c release and a secondary increase in superoxide production J. Neurosci. 20 2000 5715 5723
45. M.P. Heyes, B.J. Brew, A. Martin, R.W. Price, A.M. Salazar, J.J. Sidtis, J.A. Yergey, M.M. Mouradian, A.E. Sadler, and J. Keilp Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status Ann. Neurol. 29 1991 202 209
46. J.W. Olney, C. Zorumski, M.T. Price, and J. Labruyere L-cysteine, a bicarbonate-sensitive endogenous excitotoxin [see comments] Science 248 1990 596 599
47. D. Piani, and A. Fontana Involvement of the cystine transport system xc- in the macrophage- induced glutamate-dependent cytotoxicity to neurons J. Immunol. 152 1994 3578 3585
48. M.P. Heyes, R.J. Ellis, L. Ryan, M.E. Childers, I. Grant, T. Wolfson, S. Archibald, and T.L. Jernigan Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection Brain 124 2001 1033 1042
49. B. Viviani, E. Corsini, M. Binaglia, C.L. Galli, and M. Marinovich Reactive oxygen species generated by glia are responsible for neuron death induced by human immunodeficiency virus-glycoprotein 120 in vitro Neuroscience 107 2001 51 58
50. J. Turchan, C.B. Pocernich, C. Gairola, A. Chauhan, G. Schifitto, D.A. Butterfield, S. Buch, O. Narayan, A. Sinai, J. Geiger, J.R. Berger, H. Elford, and A. Nath Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants Neurology 60 2003 307 314
51. V. Mollace, H.S. Nottet, P. Clayette, M.C. Turco, C. Muscoli, D. Salvemini, and C.F. Perno Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants Trends Neurosci. 24 2001 411 416
52. D.C. Adamson, B. Wildemann, M. Sasaki, J.D. Glass, J.C. McArthur, V.I. Christov, T.M. Dawson, and V.L. Dawson Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41 Science 274 1996 1917 1921
53. V.L. Dawson, T.M. Dawson, G.R. Uhl, and S.H. Snyder Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures Proc. Natl. Acad. Sci USA 90 1993 3256 3259
54. S.H. Snyder Nitric oxide and neurons Curr. Opin. Neurobiol. 2 1992 323 327
55. R.S. Morrison, Y. Kinoshita, M.D. Johnson, W. Guo, and G.A. Garden p53-dependent cell death signaling in neurons Neurochem. Res. 28 2003 15 27
56. S.M. de la Monte, Y.K. Sohn, and J.R. Wands Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease J. Neurol. Sci. 152 1997 73 83
57. S.M. de la Monte, Y.K. Sohn, N. Ganju, and J.R. Wands P53- and CD95-associated apoptosis in neurodegenerative diseases Lab. Invest. 78 1998 401 411
58. F.M. LaFerla, C.K. Hall, L. Ngo, and G. Jay Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice J. Clin. Invest. 98 1996 1626 1632
59. Y.H. Jiang, D. Armstrong, U. Albrecht, C.M. Atkins, J.L. Noebels, G. Eichele, J.D. Sweatt, and A.L. Beaudet Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation [see comments] Neuron 21 1998 799 811
60. A. Sawa Neuronal cell death in Down's syndrome J. Neural. Transm. Suppl. 57 1999 87 97
61. R. Seidl, S. Fang-Kircher, B. Bidmon, N. Cairns, and G. Lubec Apoptosis-associated proteins p53 and APO-1/Fas (CD95) in brains of adult patients with Down syndrome Neurosci. Lett. 260 1999 9 12
62. L.J. Martin p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis Neurobiol. Dis. 7 2000 613 622
63. J.S. Steffan, A. Kazantsev, O. Spasic-Boskovic, M. Greenwald, Y.Z. Zhu, H. Gohler, E.E. Wanker, G.P. Bates, D.E. Housman, and L.M. Thompson The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription Proc. Natl. Acad. Sci. USA 97 2000 6763 6768
64. M.D. Shahbazian, H.T. Orr, and H.Y. Zoghbi Reduction of Purkinje cell pathology in SCA1 transgenic mice by p53 deletion Neurobiol. Dis. 8 2001 974 981
65. M.D. Johnson, Y. Kinoshita, H. Xiang, S. Ghatan, and R.S. Morrison Contribution of p53-dependent caspase activation to neuronal cell death declines with neuronal maturation J. Neurosci. 19 1999 2996 3006
66. A. Fortin, S.P. Cregan, J.G. MacLaurin, N. Kushwaha, E.S. Hickman, C.S. Thompson, A. Hakim, P.R. Albert, F. Cecconi, K. Helin, D.S. Park, and R.S. Slack APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death J. Cell Biol. 155 2001 207 216
67. G.A. Garden, W. Guo, S. Jayadev, C. Tun, S. Balcaitis, J. Choi, T.J. Montine, T. Moller, and R.S. Morrison HIV associated neurodegeneration requires p53 in neurons and microglia FASEB J. 18 2004 1141 1143
68. M.P. Mattson, D.S. Gary, S.L. Chan, and W. Duan Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer's disease Biochem. Soc. Symp. 67 2001 151 162
69. N.D. Marchenko, A. Zaika, and U.M. Moll Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling J. Biol. Chem. 275 2000 16202 16212
70. C. Sansome, A. Zaika, N.D. Marchenko, and U.M. Moll Hypoxia death stimulus induces translocation of p53 protein to mitochondria. Detection by immunofluorescence on whole cells FEBS Lett. 488 2001 110 115
71. P. Dumont, J.I. Leu, A.C. Della Pietra III, D.L. George, and M. Murphy The codon 72 polymorphic variants of p53 have markedly different apoptotic potential Nat. Genet. 33 2003 357 365
72. P. Bonini, S. Cicconi, A. Cardinale, C. Vitale, A.L. Serafino, M.T. Ciotti, and L.N. Marlier Oxidative stress induces p53-mediated apoptosis in glia: p53 transcription-independent way to die J. Neurosci. Res. 75 2004 83 95
73. J.E. Chipuk, U. Maurer, D.R. Green, and M. Schuler Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription Cancer Cell 4 2003 371 381
74. M. Mihara, S. Erster, A. Zaika, O. Petrenko, T. Chittenden, P. Pancoska, and U.M. Moll p53 has a direct apoptogenic role at the mitochondria Mol. Cell 11 2003 577 590
75. J.E. Chipuk, T. Kuwana, L. Bouchier-Hayes, N.M. Droin, D.D. Newmeyer, M. Schuler, and D.R. Green Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis Science 303 2004 1010 1014
76. J.I. Leu, P. Dumont, M. Hafey, M.E. Murphy, and D.L. George Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex Nat. Cell Biol. 6 2004 443 450
77. C.P. Gilman, S.L. Chan, Z. Guo, X. Zhu, N. Greig, and M.P. Mattson p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults Neuromolecular Med. 3 2003 159 172
78. S. Sakhi, A. Bruce, N. Sun, G. Tocco, M. Baudry, and S.S. Schreiber p53 induction is associated with neuronal damage in the central nervous system Proc. Natl. Acad. Sci. USA 91 1994 7525 7529
79. S. Sakhi, N. Sun, L.L. Wing, P. Mehta, and S.S. Schreiber Nuclear accumulation of p53 protein following kainic acid-induced seizures Neuroreport 7 1996 493 496
80. M. Nakai, Z.H. Qin, J.F. Chen, Y. Wang, and T.N. Chase Kainic acid-induced apoptosis in rat striatum is associated with nuclear factor-kappaB activation J. Neurochem. 74 2000 647 658
81. Z.H. Qin, R.W. Chen, Y. Wang, M. Nakai, D.M. Chuang, and T.N. Chase Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum J. Neurosci. 19 1999 4023 4033
82. H.G. Wang, N. Pathan, I.M. Ethell, S. Krajewski, Y. Yamaguchi, F. Shibasaki, F. McKeon, T. Bobo, T.F. Franke, and J.C. Reed Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD Science 284 1999 339 343
83. S. Sakhi, A. Bruce, N. Sun, G. Tocco, M. Baudry, and S.S. Schreiber Induction of tumor suppressor p53 and DNA fragmentation in organotypic hippocampal cultures following excitotoxin treatment Exp. Neurol. 145 1997 81 88
84. D. Uberti, M. Belloni, M. Grilli, P. Spano, and M. Memo Induction of tumour-suppressor phosphoprotein p53 in the apoptosis of cultured rat cerebellar neurones triggered by excitatory amino acids Eur. J. Neurosci. 10 1998 246 254
85. R.W. Chen, and D.M. Chuang Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity J. Biol. Chem. 274 1999 6039 6042
86. M. Djebaili, G. Rondouin, V. Baille, and J. Bockaert p53 and Bax implication in NMDA induced-apoptosis in mouse hippocampus Neuroreport 11 2000 2973 2976
87. J. Jordan, M.F. Galindo, C. Gonzalez-Garcia, and V. Cena Role and regulation of p53 in depolarization-induced neuronal death Neuroscience 122 2003 707 715
88. R.W. Chen, Z.H. Qin, M. Ren, H. Kanai, E. Chalecka-Franaszek, P. Leeds, and D.M. Chuang Regulation of c-Jun N-terminal kinase, p38 kinase and AP-1 DNA binding in cultured brain neurons: roles in glutamate excitotoxicity and lithium neuroprotection J. Neurochem. 84 2003 566 575
89. H. Guo, D. Liu, H. Gelbard, T. Cheng, R. Insalaco, J.A. Fernandez, J.H. Griffin, and B.V. Zlokovic Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3 Neuron 41 2004 563 572
90. J.A. Napieralski, R. Raghupathi, and T.K. McIntosh The tumor-suppressor gene, p53, is induced in injured brain regions following experimental traumatic brain injury Brain Res. Mol. Brain Res. 71 1999 78 86
91. J. Lu, S. Moochhala, C. Kaur, and E. Ling Changes in apoptosis-related protein (p53, Bax, Bcl-2 and Fos) expression with DNA fragmentation in the central nervous system in rats after closed head injury Neurosci. Lett. 290 2000 89 92
92. L.J. Martin, A. Kaiser, J.W. Yu, J.E. Natale, and N.A. Al-Abdulla Injury-induced apoptosis of neurons in adult brain is mediated by p53- dependent and p53-independent pathways and requires Bax J. Comp. Neurol. 433 2001 299 311
93. L.J. Martin, A.C. Price, K.B. McClendon, N.A. Al-Abdulla, J.R. Subramaniam, P.C. Wong, and Z. Liu Early events of target deprivation/axotomy- induced neuronal apoptosis in vivo: oxidative stress, DNA damage, p53 phosphorylation and subcellular redistribution of death proteins J. Neurochem. 85 2003 234 247
94. B. Zhivotovsky, and G. Kroemer Apoptosis and genomic instability Nat. Rev. Mol. Cell Biol. 5 2004 752 762
95. E. Tamagno, M. Parola, M. Guglielmotto, G. Santoro, P. Bardini, L. Marra, M. Tabaton, and O. Danni Multiple signaling events in amyloid beta-induced, oxidative stress-dependent neuronal apoptosis Free Radic. Biol. Med. 35 2003 45 58
96. M. Kondo, T. Shibata, T. Kumagai, T. Osawa, N. Shibata, M. Kobayashi, S. Sasaki, M. Iwata, N. Noguchi, and K. Uchida 15-Deoxy-delta(12,14)-prostaglandin J(2): the endogenous electrophile that induces neuronal apoptosis Proc. Natl. Acad. Sci. USA 99 2002 7367 7372
97. C.A. Wiley, C.L. Achim, R. Hammond, S. Love, E. Masliah, L. Radhakrishnan, V. Sanders, and G. Wang Damage and repair of DNA in HIV encephalitis J. Neuropathol. Exp. Neurol. 59 2000 955 965
98. C. Silva, K. Zhang, S. Tsutsui, J.K. Holden, M.J. Gill, and C. Power Growth hormone prevents human immunodeficiency virus-induced neuronal p53 expression Ann. Neurol. 54 2003 605 614
99. S. Krajewski, H.J. James, J. Ross, B.M. Blumberg, L.G. Epstein, H.E. Gendelman, S. Gummuluru, S. Dewhurst, L.R. Sharer, J.C. Reed, and H.A. Gelbard Expression of pro- and anti-apoptosis gene products in brains from paediatric patients with HIV-1 encephalitis Neuropathol. Appl. Neurobiol. 23 1997 242 253
100. K.L. Jordan-Sciutto, G. Wang, M. Murphey-Corb, and C.A. Wiley Cell cycle proteins exhibit altered expression patterns in lentiviral-associated encephalitis J. Neurosci. 22 2002 2185 2195
101. K.L. Jordan-Sciutto, G. Wang, M. Murphy-Corb, and C.A. Wiley Induction of cell-cycle regulators in simian immunodeficiency virus encephalitis Am. J. Pathol. 157 2000 497 507
102. B.O. Kim, Y. Liu, Y. Ruan, Z.C. Xu, L. Schantz, and J.J. He Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline Am. J. Pathol. 162 2003 1693 1707
103. W.R. Tyor, C. Power, H.E. Gendelman, and R.B. Markham A model of human immunodeficiency virus encephalitis in scid mice Proc. Natl. Acad. Sci. USA 90 1993 8658 8662
104. G.A. Garden, S.L. Budd, E. Tsai, L. Hanson, M. Kaul, D.M. D'Emilia, R.M. Friedlander, J. Yuan, E. Masliah, and S.A. Lipton Caspase cascades in human immunodeficiency virus-associated neurodegeneration J. Neurosci. 22 2002 4015 4024
105. H. Dou, K. Birusingh, J. Faraci, S. Gorantla, L.Y. Poluektova, S.B. Maggirwar, S. Dewhurst, H.A. Gelbard, and H.E. Gendelman Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis J. Neurosci. 23 2003 9162 9170
106. G.A. Turenne, and B.D. Price Glycogen synthase kinase3 beta phosphorylates serine 33 of p53 and activates p53's transcriptional activity BMC Cell Biol. 2 2001 12
107. P. Watcharasit, G.N. Bijur, L. Song, J. Zhu, X. Chen, and R.S. Jope Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53 J. Biol. Chem. 278 2003 48872 48879
108. B.Y. Zhou, and J.J. He Proliferation inhibition of astrocytes, neurons, and non-glial cells by intracellularly expressed human immunodeficiency virus type 1 (HIV-1) Tat protein Neurosci. Lett. 359 2004 155 158
109. D.L. Kolson, R. Collman, R. Hrin, J.W. Balliet, M. Laughlin, K.A. McGann, C. Debouck, and F. Gonzalez-Scarano Human immunodeficiency virus type 1 Tat activity in human neuronal cells: uptake and trans-activation J. Gen. Virol. 75 1994 1927 1934
110. M. Ma, and A. Nath Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells J. Virol. 71 1997 2495 2499
111. G.A. Garden Microglia in human immunodeficiency virus-associated neurodegeneration Glia 40 2002 240 251
112. M. Kaul, and S.A. Lipton Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis Proc. Natl. Acad. Sci. USA 96 1999 8212 8216
113. B.E. Sawaya, K. Khalili, W.E. Mercer, L. Denisova, and S. Amini Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription J. Biol. Chem. 273 1998 20052 20057
114. S. Amini, K. Khalili, and B.E. Sawaya Effect of HIV-1 Vpr on cell cycle regulators DNA Cell Biol. 23 2004 249 260
115. L.D. Shostak, J. Ludlow, J. Fisk, S. Pursell, B.J. Rimel, D. Nguyen, J.D. Rosenblatt, and V. Planelles Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr Exp. Cell Res. 251 1999 156 165
116. S. Amini, M. Saunders, K. Kelley, K. Khalili, and B.E. Sawaya Interplay between HIV-1 Vpr and Sp1 modulates p21WAF1 gene expression in human astrocytes J. Biol. Chem. 2004
117. S.L. Letendre, E.R. Lanier, and J.A. McCutchan Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1 J. Infect. Dis. 180 1999 310 319